INDIANAPOLIS--(BUSINESS WIRE)--Positron Corporation (OTCBB:POSC), a Cardiac Molecular Imaging Solutions Company, announced today the results from an independent study on radiation exposure of technologists administering FDG. The study was conducted in the Nuclear Medicine Department at Mount Sinai Medical Center in New York, N.Y. by the Director of PET, Ash Rafique. The study compared historic whole body and ring readings using a traditional syringe shield compared to Positron’s Tech-Assist™ device. The results showed a reduction in whole body badge exposure by 50%-75% and ring badge reductions of 40%-55%, compared to previous month’s data.
